Director, Regional Commercial Strategy, Autoantibody Disease

Purpose of the Role

Lead the end-to-end commercial strategy, performance, and competitiveness of the APAC Autoantibody portfolio (gMG, wAIHA, SjD, SLE), with accountability spanning:

• Early pipeline shaping

• Launch excellence (including IMAAVY and future indications)

• In-market growth and lifecycle optimization

• Positioning APAC as a critical contributor to Global Immunology strategy

Key Scope & Accountabilities

• Regional ownership of the Autoantibody portfolio across APAC

• Full lifecycle responsibility from pipeline through launch and growth

• Enterprise-level strategic planning and execution

• Investment prioritization and ROI optimization

• Leadership of cross-functional regional ecosystem and OpCo alignment

• Influence on both regional execution and global strategic direction

Six Core Responsibilities

• Portfolio Strategy & Lifecycle Leadership

• Launch Excellence & Growth Acceleration

• Competitive Strategy & Market Leadership

• Cross-Functional & Regional Leadership

• Performance Management & Investment Optimization

• People & Organizational Leadership

Success Measures

• Commercial performance across portfolio

• Market share growth

• Launch success

• Business plan execution

• Investment effectiveness

• Compliance and governance

• Cross-functional collaboration effectiveness

Qualifications

• Bachelor's degree required; MBA preferred

• A minimum of eight (8) years of professional Sales and Sales Management or Marketing and/or Marketing Management experience within the pharmaceutical, biotech, medical device or healthcare industry is required.

• A minimum of two years in Marketing and/or Marketing Management or a Commercial Excellence / Analytics function is required.

• A minimum of three (3) years of experience managing and leading a cross functional / cross geographic team is strongly preferred.

• Team leadership experience

• Therapeutic area expertise preferred

• Up to 50% travel across APAC